Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Int J Stroke. 2014 May 20;9(6):698–704. doi: 10.1111/ijs.12292

Fig. 1.

Fig. 1

Relationship between THRIVE score and outcomes among patients treated with Solitaire in SWIFT and STAR. (a) Decreasing chances of good outcome (mRS 0–2 at three-months) with increasing levels of trichotomized THRIVE score (0–2, 3–5, 6–9). The good outcomes at each level are THRIVE 0–2: 80·9% (38/47), THRIVE 3–5: 53·8% (86/160), and THRIVE 6–9: 31·0% (22/71). (P < 0·001, Mantel-Haenszel test for trend). (b) Increasing chances of death by three-months with increasing levels of trichotomized THRIVE score. The chance of death at each level is THRIVE 0–2: 4·3% (2/47), THRIVE 3–5: 8·8% (14/160), and THRIVE 6–9: 18·3% (13/71). (P < 0·001, Mantel-Haenszel test for trend). mRS, modified Rankin Scale; THRIVE, Totaled Health Risks in Vascular Events.